BioAdaptives, Inc. (BDPT)
0.002
0.00 (0.00%)
USD |
OTCM |
Oct 12, 16:00
BioAdaptives EPS Diluted (Quarterly) : 0.0106 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0106 |
| March 31, 2026 | -0.0092 |
| December 31, 2025 | -0.0686 |
| September 30, 2025 | -0.0371 |
| June 30, 2025 | -0.0166 |
| March 31, 2025 | -0.0218 |
| December 31, 2024 | -0.0226 |
| September 30, 2024 | -0.012 |
| June 30, 2024 | -0.06 |
| March 31, 2024 | -0.093 |
| December 31, 2023 | -0.09 |
| September 30, 2023 | -0.006 |
| June 30, 2023 | -0.099 |
| March 31, 2023 | -0.321 |
| December 31, 2022 | -0.033 |
| September 30, 2022 | -0.927 |
| June 30, 2022 | -0.993 |
| March 31, 2022 | -2.052 |
| December 31, 2021 | -1.422 |
| September 30, 2021 | -0.306 |
| June 30, 2021 | -2.808 |
| March 31, 2021 | -5.244 |
| December 31, 2020 | -2.385 |
| September 30, 2020 | -0.195 |
| June 30, 2020 | -6.513 |
| Date | Value |
|---|---|
| March 31, 2020 | -3.768 |
| December 31, 2019 | -1.56 |
| September 30, 2019 | -0.879 |
| June 30, 2019 | -2.907 |
| March 31, 2019 | -1.404 |
| December 31, 2018 | -6.033 |
| September 30, 2018 | -11.75 |
| June 30, 2018 | -7.341 |
| March 31, 2018 | -0.084 |
| December 31, 2017 | -0.453 |
| September 30, 2017 | -0.048 |
| June 30, 2017 | -0.0585 |
| March 31, 2017 | -0.102 |
| December 31, 2016 | -0.654 |
| September 30, 2016 | -0.558 |
| June 30, 2016 | -0.702 |
| March 31, 2016 | -3.00 |
| December 31, 2015 | -1.143 |
| September 30, 2015 | -0.945 |
| June 30, 2015 | -3.00 |
| March 31, 2015 | -0.699 |
| December 31, 2014 | -54.57 |
| September 30, 2014 | -0.534 |
| June 30, 2014 | -6.00 |
| March 31, 2014 | -0.21 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ashland, Inc. | 0.3478 |
| Achieve Life Sciences, Inc. | -0.7996 |
| CBD Life Sciences, Inc. | 0.00 |
| BellRing Brands, Inc. | 0.2933 |
| Aspire-Lakewood Holdings, Inc. | -1.222 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.1501M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | -0.1451M |
| Enterprise Value | 0.5668M |
| Gross Profit Margin (Quarterly) | 54.00% |
| Earnings Yield | -5.22K% |
| Normalized Earnings Yield | -4945.00 |